Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sagent Pharmaceuticals has launched ciprofloxacin injection, USP, 5% dextrose premix bag, a synthetic broad spectrum antimicrobial agent for intravenous administration used to treat bacterial infections.
Subscribe to our email newsletter
Sagent’s ciprofloxacin injection will be available immediately in 200mg and 400mg premix bags. Ciprofloxacin injection, USP, is a synthetic broad spectrum antimicrobial agent and is the generic equivalent of Bayer Pharmaceuticals’s Cipro I.V.
Jeffrey Yordon, CEO and founder of Sagent, said: “The launch of our ciprofloxacin further demonstrates Sagent’s capabilities and expertise in injectable pharmaceutical products and our seasoned management team’s commitment to the needs of patients and customers.”